{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:31:57Z","timestamp":1740123117240,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["core Grant"],"award-info":[{"award-number":["core Grant"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11033-019-04950-0","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T11:05:51Z","timestamp":1562583951000},"page":"4997-5003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients"],"prefix":"10.1007","volume":"46","author":[{"given":"Somprakash","family":"Dhangar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrakala","family":"Shanmukhaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4783-2691","authenticated-orcid":false,"given":"Babu Rao","family":"Vundinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"4950_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/213790","volume":"2014","author":"C Banescu","year":"2014","unstructured":"Banescu C, Trifa AP, Demian S et al (2014) Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia. Biomed Res Int 2014:1\u20139","journal-title":"Biomed Res Int"},{"issue":"6","key":"4950_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 122(6):872\u2013884","journal-title":"Blood"},{"issue":"5","key":"4950_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.clinthera.2010.05.003","volume":"32","author":"B Stein","year":"2010","unstructured":"Stein B, Smith BD (2010) Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate Imatinib. Clin Ther 32(5):804\u2013820","journal-title":"Clin Ther"},{"key":"4950_CR4","first-page":"2453","volume":"27","author":"U Deligezer","year":"2007","unstructured":"Deligezer U, Akisik EE, Dalay N (2007) Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia. Anticancer Res 27:2453\u20132456","journal-title":"Anticancer Res"},{"key":"4950_CR5","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/nar\/28.10.2049","volume":"28","author":"A Marintchev","year":"2000","unstructured":"Marintchev A, Robertson A, Dimitriadis EK, Prasad R, Wilson SH, Mullen GP (2000) Domain specific interaction in the XRCC1-DNA polymerase beta complex. Nucleic Acids Res 28:2049\u20132059","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"4950_CR6","doi-asserted-by":"publisher","first-page":"35848","DOI":"10.18632\/oncotarget.16261","volume":"8","author":"P Carrera-Lasfuentes","year":"2017","unstructured":"Carrera-Lasfuentes P, Lanas A, Bujanda L et al (2017) Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype. Oncotarget 8(22):35848\u201335862","journal-title":"Oncotarget"},{"issue":"28","key":"4950_CR7","doi-asserted-by":"publisher","first-page":"22476","DOI":"10.1007\/s11356-017-9767-x","volume":"24","author":"M Feki-Tounsi","year":"2017","unstructured":"Feki-Tounsi M, Khlifi R, Louati I et al (2017) Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population. Environ Sci Pollut Res Int 24(28):22476\u201322484","journal-title":"Environ Sci Pollut Res Int"},{"issue":"1","key":"4950_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12253-017-0322-3","volume":"25","author":"A Ozgoz","year":"2019","unstructured":"Ozgoz A, Hekimler Ozturk K, Yukselturk A et al (2019) Genetic variations of DNA repair genes in breast cancer. Pathol Oncol Res 25(1):107\u2013114","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"4950_CR9","first-page":"1","volume":"15","author":"LJ Wang","year":"2016","unstructured":"Wang LJ, Wang HT, Wang XX (2016) Association of XRCC1 gene polymorphisms and pancreatic cancer risk in a Chinese population. Genet Mol Res 15(2):1\u20137","journal-title":"Genet Mol Res"},{"key":"4950_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/jnci\/djn188","volume":"100","author":"J Wu","year":"2008","unstructured":"Wu J, Meng F, Kong LY et al (2008) Association between Imatinib-resistant BCR-ABL mutation negative leukemia and persistent activation of LYN kinase. J Natl Cancer Inst 100:926\u2013939","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4950_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","volume":"102","author":"S Branford","year":"2003","unstructured":"Branford S, Rudzki Z, Walsh S et al (2003) Detection of BCR-ABL mutations in patients with treated with Imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate binding loop (P-loop) are associated with a poor prognosis. Blood 102(1):276\u2013283","journal-title":"Blood"},{"key":"4950_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/107327480901600204","volume":"16","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Kantarjian HM, Cortes JE et al (2009) Mechanisms of primary and secondary resistance to Imatinib in chronic myeloid leukemia. Cancer Control 16:122\u2013131","journal-title":"Cancer Control"},{"key":"4950_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K et al (2001) Clinical resistance to STI-571 cancer therapy caused by BCR\u2013ABL gene mutation or amplification. Science 293:876\u2013880","journal-title":"Science"},{"key":"4950_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1158\/0008-5472.CAN-03-1484","volume":"64","author":"NJ Donato","year":"2004","unstructured":"Donato NJ, Wu JY, Stapley J et al (2004) Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res 64:672\u2013677","journal-title":"Cancer Res"},{"key":"4950_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1365-2141.2002.03784.x","volume":"119","author":"FJ Giles","year":"2002","unstructured":"Giles FJ, Kantarjian HM, Bekele BN et al (2002) Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukemia and are associated with reduced survival. Br J Haematol 119:38\u201345","journal-title":"Br J Haematol"},{"key":"4950_CR16","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766","volume":"95","author":"P Le Coutre","year":"2000","unstructured":"Le Coutre P, Tassi E, Varella-Garcia M et al (2000) Induction of resistance to Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood 95:1758\u20131766","journal-title":"Blood"},{"key":"4950_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00580-010-1120-4","volume":"21","author":"MS El-din","year":"2012","unstructured":"El-din MS, Raslan H, Hamid SA et al (2012) Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia. Comp Clin Pathol 21:505\u2013513","journal-title":"Comp Clin Pathol"},{"key":"4950_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.onc.1209756","volume":"26","author":"ET Penserga","year":"2007","unstructured":"Penserga ET, Skorski T (2007) Fusion tyrosine kinases: a result and cause of genomic instability. Oncogene 26:11\u201320","journal-title":"Oncogene"},{"key":"4950_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/35015097","volume":"405","author":"C Richardson","year":"2000","unstructured":"Richardson C, Jasin M (2000) Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405:697\u2013700","journal-title":"Nature"},{"issue":"11","key":"4950_CR20","doi-asserted-by":"publisher","first-page":"27535","DOI":"10.3390\/ijms161126049","volume":"16","author":"E Pawlowska","year":"2015","unstructured":"Pawlowska E, Blasiak J (2015) DNA repair-a double-edged sword in the genomic stability of cancer cells-the case of chronic myeloid leukemia. Int J Mol Sci 16(11):27535\u201327549","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4950_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s13277-015-3874-4","volume":"37","author":"H Salimizand","year":"2016","unstructured":"Salimizand H, Amini S, Abdi M, Ghaderi B, Azadi NA (2016) Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with Imatinib mesylate in patients with chronic myeloid leukemia. Tumour Biol 37(1):791\u2013798","journal-title":"Tumour Biol"},{"key":"4950_CR22","first-page":"3277","volume":"8","author":"F Wang","year":"2015","unstructured":"Wang F, Zhao Q, He HR, Zhai YJ, Lu J, Hu HB, Zhou JS, Yang YH, Li YJ (2015) The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies. Onco Targets Ther 8:3277\u20133287","journal-title":"Onco Targets Ther"},{"issue":"4","key":"4950_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","volume":"21","author":"RM Lunn","year":"2000","unstructured":"Lunn RM, Helzlsouer KJ, Parshad R et al (2000) XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21(4):551\u2013555","journal-title":"Carcinogenesis"},{"issue":"7","key":"4950_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ajh.21726","volume":"85","author":"VM Guillem","year":"2010","unstructured":"Guillem VM, Cervantes F, Martinez J et al (2010) XPC genetic polymorphisms correlate with the response to Imatinib treatment in patients with chronic phase chronic myeloid leukemia. Am J Hematol 85(7):482\u2013486","journal-title":"Am J Hematol"},{"key":"4950_CR25","doi-asserted-by":"publisher","first-page":"8860","DOI":"10.5897\/AJB10.1839","volume":"10","author":"A Ozcan","year":"2011","unstructured":"Ozcan A, Pehlivan M, Karaca E, Ozk\u0131nay C (2011) Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in Turkish population. Afr J Biotechnol 10:8860\u20138870","journal-title":"Afr J Biotechnol"},{"issue":"3","key":"4950_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/gtmb.2012.0278","volume":"17","author":"A Sorour","year":"2013","unstructured":"Sorour A, Ayad MW, Kassem H (2013) DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarker 17(3):195\u2013201","journal-title":"Genet Test Mol Biomarker"},{"issue":"8","key":"4950_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/carcin\/23.8.1321","volume":"23","author":"S Chen","year":"2002","unstructured":"Chen S, Tang D, Xue K et al (2002) DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23(8):1321\u20131325","journal-title":"Carcinogenesis"},{"issue":"1","key":"4950_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/1055-9965.EPI-03-0053","volume":"13","author":"BA Rybicki","year":"2004","unstructured":"Rybicki BA, Conti DV, Moreira A et al (2004) DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 13(1):23\u201329","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-04950-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-04950-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-04950-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:14:25Z","timestamp":1594077265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-04950-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4950"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-04950-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}